Canada's first Health Canada-approved clinical medical cannabis trial launches VON cost cuts worry nurses union Consider antibiotics first for appendicitis Vitals: Who is paying for prescribed drugs in Canada? Case Report: Irritating lesions afflict patient’s flexural areas SGLT2 inhibitors: possible link to an increased risk of ketoacidosis Health Canada begins safety review for “flozin” drug class. UNESCO renews pact with FIP for global pharmaceutical education Global Pharmacy Education Development Network (GPhEd) continues another four years. Does sitagliptin increase cardiovascular risk in diabetes patients? New study shows no apparent increased risk of major adverse cardiovascular events or hospitalization for heart failure. Missed opportunities: Jail and prison are a chance to improve health UV: from cancer to photodermatoses First Previous 1464 1465 1466 1467 1468 Next Last
